101 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Gossamer Bio Statement of Operations
Condensed
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
For Investors
8-K
EX-99.1
GOSS
Gossamer Bio Inc
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
harbor provisions of the Private Securities Litigation Reform Act of 1995.
GOSSAMER BIO, INC.
CONDENSED CONSOLIDATED FINANCIAL STATEMENT DATA
8-K
EX-10.1
v245q42 qftst
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
lgfagjz9r0r90gv 03o
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
424B3
x985h hf74atyfkhedf
28 Aug 23
Prospectus supplement
4:29pm
S-3
y5oci3d9z
18 Aug 23
Shelf registration
8:41am
S-3ASR
47kajnxjm3b69179ul
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
drbg2u cllgh
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-10.1
95uplafm g8ur3qi
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
qbw3ymr wbhn
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
v0n9l
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-99.1
22d7621
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
ratat2hcn 3if
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm